Learn More
Medchemexpress LLC Gemigliptin tartrate | 1374639-74-3 | 99.5% | 639.45 | 50 MG

Supplier: Medchemexpress LLC HY14892A50MG
Gemigliptin tartrate is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be utilized for research into advanced glycation end products (AGE)-related diabetic complications.
- Highly selective, reversible, and competitive DPP-4 inhibitor
- Exhibits potent anti-glycation properties
- Can be used for research into advanced glycation end products (AGE)-related diabetic complications
- Inhibits the formation of AGE-BSA
- Suppresses the cross-linking of preformed AGE-BSA
- Dose-dependently inhibits plasma DPP-4 activity in rats, dogs, and monkeys
- Significantly reduces circulating AGE levels in serum in vivo
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.